Zanosar

Zanosar (Streptozocin) is an intravenous chemotherapy agent used primarily for pancreatic cancer. This alkylating drug works by slowing or stopping cancer cell growth. Always consult a healthcare provider for proper use and dosage.

Zanosar is primarily used to treat pancreatic islet cell carcinoma, a type of pancreatic cancer. It may also be prescribed for other cancers as determined by a physician. This medication belongs to the class of alkylating agents, which interfere with cancer cell reproduction. Patients often ask, 'what is Zanosar used for' in the context of cancer treatment.

Zanosar is designed to target rapidly dividing cells, which includes cancer cells. Common effects may include nausea, vomiting, or fatigue during treatment. Some patients report changes in kidney function or blood cell counts, which are monitored by healthcare providers.

Zanosar requires careful administration by a healthcare professional due to its potent effects. Patients should discuss their full medical history, including kidney or liver conditions, before starting treatment. Regular blood tests are typically required to monitor for potential side effects.

Zanosar may interact with other medications that affect the kidneys or bone marrow, such as certain chemotherapy drugs or immunosuppressants. Alcohol and other substances metabolized by the liver should be avoided unless approved by a doctor. Always inform your healthcare provider about all medications and supplements you are taking.